Fig. 2From: A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)Power curves for excluding a proportion of unfavourable outcomes under different assumptions of the true proportion, assuming (a) 60, (b) 80, and (c) 100 patients per arm for a STEP trial. Numbers on graphs show the proportion of unfavourable outcomes that could be excluded at the upper bound of the 90Â % two-sided confidence interval (95Â % one-sided confidence interval, CI) with 80Â % and 90Â % powerBack to article page